Company / SG&A per Share
EyePoint, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.76
FY2025
5-year range
$0.76 / $1.14
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
#143 of 156
Health Care
What the data says
Among 156 Health Care companies, EyePoint, Inc. is in the top 8% for sg&a per share. SG&A per Share has declined for 5 consecutive years, from $1.64 in FY2020 to $0.76 in FY2025.
Based on SEC 10-K filings.
0.76 in FY2025 with a 5-year CAGR of -14.3%.
Improved from $1.02 to $0.76 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -9.7%
- 5-Year CAGR
- -14.3%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 156This company $0.76 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- EyePoint, Inc.'s sg&a per share has declined for 5 consecutive years.
- In FY2025, sg&a per share decreased 7.5% year-over-year.
- Ranks #143 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.76 | -7.5% |
| FY2024 | $0.82 | -20.0% |
| FY2023 | $1.02 | -0.5% |
| FY2022 | $1.03 | -10.1% |
| FY2021 | $1.14 | -30.3% |
| FY2020 | $1.64 | +1291.8% |
| FY2019 | $0.12 | -59.8% |
| FY2018 | $0.29 | -10.8% |
| FY2017 | $0.33 | +7.3% |
| FY2016 | $0.31 | +25.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026